Recruiting
Neoplasm malignant+1
RecruitingA Phase I/II Study of GVV858 Alone or in Drug Combination for Patients with Advanced Hormone Receptor‑Positive, HER2‑Negative Breast Cancer
Registered drugNo placebo
A Phase I/II Study of GVV858 Alone or in Drug Combination for Patients with Advanced Hormone Receptor‑Positive, HER2‑Negative Breast Cancer
Registered drugNo placebo
- Disease:Neoplasm malignantHormone receptor positive HER2 negative breast cancer
- Substances:FulvestrantGoserelin+3
Countries:
Czechia
Czechia- Participants:18–64 years · 65+ years
- Substances:Fulvestrant
